Inhibition of transcription by dactinomycin reveals a new characteristic of immunogenic cell stress-Reference-Cited by-同舟云学术

Inhibition of transcription by dactinomycin reveals a new characteristic of immunogenic cell stress

Published:2020-04-23 Issue:5 Volume:12 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Humeau Juliette¹²³,Sauvat Allan¹²,Cerrato Giulia¹²³,Xie Wei¹²³,Loos Friedemann¹²^ORCID,Iannantuoni Francesca¹²⁴,Bezu Lucillia¹²⁴,Lévesque Sarah¹²³,Paillet Juliette¹²³,Pol Jonathan¹²^ORCID,Leduc Marion¹²,Zitvogel Laurence³⁵⁶⁷,de Thé Hugues⁸⁹,Kepp Oliver¹²^ORCID,Kroemer Guido¹²¹⁰¹¹¹²^ORCID

Affiliation:

1. Equipe labellisée par la Ligue contre le Cancer Sorbonne Université INSERM UMR1138 Centre de Recherche des Cordeliers Université de Paris Paris France

2. Metabolomics and Cell Biology Platforms Gustave Roussy Villejuif France

3. Faculty of Medicine Kremlin Bicêtre Université Paris Sud, Paris Saclay Paris France

4. Hospital Doctor Peset ‐ FISABIO Valencia Spain

5. Gustave Roussy Cancer Campus (GRCC) Villejuif France

6. INSERM U1015 Villejuif France

7. Center of Clinical Investigations in Biotherapies of Cancer (CICBT) Villejuif France

8. College de France INSERM UMR 1050, CNRS UMR 7241 PSL University Paris France

9. INSERM UMR 944, CNRS UMR 7212 Equipe labellisée par la Ligue contre le Cancer IRSL, Hopital St. Louis Université de Paris Paris France

10. Suzhou Institute for Systems Medicine Chinese Academy of Medical Sciences Suzhou China

11. Pôle de Biologie Hôpital Européen Georges Pompidou, AP‐HP Paris France

12. Department of Women's and Children's Health Karolinska Institutet Karolinska University Hospital Stockholm Sweden

Funder

Institut Universitaire de France

China Scholarship Council

Bristol-Myers Squibb

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.201911622

Reference74 articles.

1. Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapy

2. Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

3. Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade

4. Inhibition of formyl peptide receptor 1 reduces the efficacy of anticancer chemotherapy against carcinogen-induced breast cancer

5. Inhibiting eukaryotic transcription. Which compound to choose? How to evaluate its activity?

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug Repurposing of Selected Antibiotics: An Emerging Approach in Cancer Drug Discovery;ACS Omega;2024-06-13

2. Targeting immunogenic cell stress and death for cancer therapy;Nature Reviews Drug Discovery;2024-04-15

3. HIF-1α Mediates Immunosuppression and Chemoresistance in Colorectal Cancer by Inhibiting CXCL9, −10 and −11;Biomedicine & Pharmacotherapy;2024-04

4. DAMPening Tumor Immune Escape: The Role of Endoplasmic Reticulum Chaperones in Immunogenic Chemotherapy;Antioxidants & Redox Signaling;2024-03-22

5. Immunogenic cell stress and death in the treatment of cancer;Seminars in Cell & Developmental Biology;2024-03